APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sanger Sequencers

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sanger Sequencers Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchSanger Sequencers Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Sanger Sequencers Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Sanger Sequencers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sanger Sequencers Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Sanger Sequencers Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Sanger Sequencers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sanger Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sanger Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sanger Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sanger Sequencers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sanger Sequencers market include Danaher, Promega, Denogen (Beijing) Bio-Sci&Tech, Ningbo HEALTH Gene Technologies, Thermo Fisher Scientific and Superyears Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sanger Sequencers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sanger Sequencers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sanger Sequencers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sanger Sequencers market size, projected growth trends, production technologies, key applications, and end-use industries.

Sanger Sequencers Segment by Company

Danaher

Promega

Denogen (Beijing) Bio-Sci&Tech

Ningbo HEALTH Gene Technologies

Thermo Fisher Scientific

Superyears Gene

Sanger Sequencers Segment by Type

4-Channel

8-Channel

Others

Sanger Sequencers Segment by Application

Clinical Testing

Scientific Research

Sanger Sequencers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sanger Sequencers status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sanger Sequencers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sanger Sequencers significant trends, drivers, influence factors in global and regions.

6. To analyze Sanger Sequencers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sanger Sequencers market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sanger Sequencers industry.

Chapter 3: Detailed analysis of Sanger Sequencers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sanger Sequencers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sanger Sequencers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sanger Sequencers Industry Trends Table 2. Sanger Sequencers Industry Drivers Table 3. Sanger Sequencers Industry Opportunities and Challenges Table 4. Sanger Sequencers Industry Restraints Table 5. Global Sanger Sequencers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sanger Sequencers Revenue Share by Company (2021-2026) Table 7. Global Sanger Sequencers Sales Volume by Company (Units) & (2021-2026) Table 8. Global Sanger Sequencers Sales Volume Share by Company (2021-2026) Table 9. Global Sanger Sequencers Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sanger Sequencers Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sanger Sequencers Key Company Manufacturing Base & Headquarters Table 12. Global Sanger Sequencers Company, Product Type & Application Table 13. Global Sanger Sequencers Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sanger Sequencers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 4-Channel Table 18. Significant Companies of 8-Channel Table 19. Significant Companies of Others Table 20. Global Sanger Sequencers Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Sanger Sequencers Sales Volume by Type (2021-2026) & (Units) Table 22. Global Sanger Sequencers Sales Volume by Type (2027-2032) & (Units) Table 23. Global Sanger Sequencers Sales Volume Share by Type (2021-2026) Table 24. Global Sanger Sequencers Sales Volume Share by Type (2027-2032) Table 25. Global Sanger Sequencers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Sanger Sequencers Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Sanger Sequencers Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Sanger Sequencers Sales Value Share by Type (2021-2026) Table 29. Global Sanger Sequencers Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinical Testing Table 31. Significant Companies of Scientific Research Table 32. Global Sanger Sequencers Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Sanger Sequencers Sales Volume by Application (2021-2026) & (Units) Table 34. Global Sanger Sequencers Sales Volume by Application (2027-2032) & (Units) Table 35. Global Sanger Sequencers Sales Volume Share by Application (2021-2026) Table 36. Global Sanger Sequencers Sales Volume Share by Application (2027-2032) Table 37. Global Sanger Sequencers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sanger Sequencers Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sanger Sequencers Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sanger Sequencers Sales Value Share by Application (2021-2026) Table 41. Global Sanger Sequencers Sales Value Share by Application (2027-2032) Table 42. Global Sanger Sequencers Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Sanger Sequencers Sales by Region (2021-2026) & (Units) Table 44. Global Sanger Sequencers Sales Market Share by Region (2021-2026) Table 45. Global Sanger Sequencers Sales by Region (2027-2032) & (Units) Table 46. Global Sanger Sequencers Sales Market Share by Region (2027-2032) Table 47. Global Sanger Sequencers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sanger Sequencers Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sanger Sequencers Sales Value Share by Region (2021-2026) Table 50. Global Sanger Sequencers Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sanger Sequencers Sales Value Share by Region (2027-2032) Table 52. Global Sanger Sequencers Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Sanger Sequencers Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Sanger Sequencers Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Sanger Sequencers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sanger Sequencers Sales by Country (2021-2026) & (Units) Table 57. Global Sanger Sequencers Sales Market Share by Country (2021-2026) Table 58. Global Sanger Sequencers Sales by Country (2027-2032) & (Units) Table 59. Global Sanger Sequencers Sales Market Share by Country (2027-2032) Table 60. Global Sanger Sequencers Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sanger Sequencers Sales Value Market Share by Country (2021-2026) Table 62. Global Sanger Sequencers Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sanger Sequencers Sales Value Market Share by Country (2027-2032) Table 64. Danaher Company Information Table 65. Danaher Business Overview Table 66. Danaher Sanger Sequencers Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Danaher Sanger Sequencers Product Portfolio Table 68. Danaher Recent Development Table 69. Promega Company Information Table 70. Promega Business Overview Table 71. Promega Sanger Sequencers Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Promega Sanger Sequencers Product Portfolio Table 73. Promega Recent Development Table 74. Denogen (Beijing) Bio-Sci&Tech Company Information Table 75. Denogen (Beijing) Bio-Sci&Tech Business Overview Table 76. Denogen (Beijing) Bio-Sci&Tech Sanger Sequencers Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Denogen (Beijing) Bio-Sci&Tech Sanger Sequencers Product Portfolio Table 78. Denogen (Beijing) Bio-Sci&Tech Recent Development Table 79. Ningbo HEALTH Gene Technologies Company Information Table 80. Ningbo HEALTH Gene Technologies Business Overview Table 81. Ningbo HEALTH Gene Technologies Sanger Sequencers Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Ningbo HEALTH Gene Technologies Sanger Sequencers Product Portfolio Table 83. Ningbo HEALTH Gene Technologies Recent Development Table 84. Thermo Fisher Scientific Company Information Table 85. Thermo Fisher Scientific Business Overview Table 86. Thermo Fisher Scientific Sanger Sequencers Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Thermo Fisher Scientific Sanger Sequencers Product Portfolio Table 88. Thermo Fisher Scientific Recent Development Table 89. Superyears Gene Company Information Table 90. Superyears Gene Business Overview Table 91. Superyears Gene Sanger Sequencers Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Superyears Gene Sanger Sequencers Product Portfolio Table 93. Superyears Gene Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Sanger Sequencers Distributors List Table 97. Sanger Sequencers Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Sanger Sequencers Product Image Figure 2. Global Sanger Sequencers Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sanger Sequencers Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sanger Sequencers Sales (2021-2032) & (Units) Figure 5. Global Sanger Sequencers Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sanger Sequencers Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 4-Channel Image Figure 10. 8-Channel Image Figure 11. Others Image Figure 12. Global Sanger Sequencers Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Sanger Sequencers Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Sanger Sequencers Sales Volume Share by Type (2021-2032) Figure 15. Global Sanger Sequencers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Sanger Sequencers Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Sanger Sequencers Sales Value Share by Type (2021-2032) Figure 18. Clinical Testing Image Figure 19. Scientific Research Image Figure 20. Global Sanger Sequencers Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Sanger Sequencers Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sanger Sequencers Sales Volume Share by Application (2021-2032) Figure 23. Global Sanger Sequencers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sanger Sequencers Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sanger Sequencers Sales Value Share by Application (2021-2032) Figure 26. Global Sanger Sequencers Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Sanger Sequencers Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sanger Sequencers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sanger Sequencers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sanger Sequencers Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sanger Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sanger Sequencers Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sanger Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sanger Sequencers Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sanger Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sanger Sequencers Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sanger Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sanger Sequencers Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sanger Sequencers Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sanger Sequencers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sanger Sequencers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sanger Sequencers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sanger Sequencers Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sanger Sequencers Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 4-Channel
  • 8-Channel
  • Others
Applications
  • Clinical Testing
  • Scientific Research
Companies covered
  • Danaher
  • Promega
  • Denogen (Beijing) Bio-Sci&Tech
  • Ningbo HEALTH Gene Technologies
  • Thermo Fisher Scientific
  • Superyears Gene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sanger Sequencers Sales Value (2021-2032)
  4. 1.2.2 Global Sanger Sequencers Sales Volume (2021-2032)
  5. 1.2.3 Global Sanger Sequencers Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sanger Sequencers Market Dynamics
  1. 2.1 Sanger Sequencers Industry Trends
  2. 2.2 Sanger Sequencers Industry Drivers
  3. 2.3 Sanger Sequencers Industry Opportunities and Challenges
  4. 2.4 Sanger Sequencers Industry Restraints
3 Sanger Sequencers Market by Company
  1. 3.1 Global Sanger Sequencers Company Revenue Ranking in 2025
  2. 3.2 Global Sanger Sequencers Revenue by Company (2021-2026)
  3. 3.3 Global Sanger Sequencers Sales Volume by Company (2021-2026)
  4. 3.4 Global Sanger Sequencers Average Price by Company (2021-2026)
  5. 3.5 Global Sanger Sequencers Company Ranking (2024-2026)
  6. 3.6 Global Sanger Sequencers Company Manufacturing Base and Headquarters
  7. 3.7 Global Sanger Sequencers Company Product Type and Application
  8. 3.8 Global Sanger Sequencers Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sanger Sequencers Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sanger Sequencers Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sanger Sequencers Market by Type
  1. 4.1 Sanger Sequencers Type Introduction
  2. 4.1.1 4-Channel
  3. 4.1.2 8-Channel
  4. 4.1.3 Others
  5. 4.2 Global Sanger Sequencers Sales Volume by Type
  6. 4.2.1 Global Sanger Sequencers Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sanger Sequencers Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Sanger Sequencers Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Sanger Sequencers Sales Value by Type
  10. 4.3.1 Global Sanger Sequencers Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Sanger Sequencers Sales Value by Type (2021-2032)
  12. 4.3.3 Global Sanger Sequencers Sales Value Share by Type (2021-2032)
5 Sanger Sequencers Market by Application
  1. 5.1 Sanger Sequencers Application Introduction
  2. 5.1.1 Clinical Testing
  3. 5.1.2 Scientific Research
  4. 5.2 Global Sanger Sequencers Sales Volume by Application
  5. 5.2.1 Global Sanger Sequencers Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sanger Sequencers Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sanger Sequencers Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sanger Sequencers Sales Value by Application
  9. 5.3.1 Global Sanger Sequencers Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sanger Sequencers Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sanger Sequencers Sales Value Share by Application (2021-2032)
6 Sanger Sequencers Regional Sales and Value Analysis
  1. 6.1 Global Sanger Sequencers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sanger Sequencers Sales by Region (2021-2032)
  3. 6.2.1 Global Sanger Sequencers Sales by Region: 2021-2026
  4. 6.2.2 Global Sanger Sequencers Sales by Region (2027-2032)
  5. 6.3 Global Sanger Sequencers Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sanger Sequencers Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sanger Sequencers Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sanger Sequencers Sales Value by Region (2027-2032)
  9. 6.5 Global Sanger Sequencers Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sanger Sequencers Sales Value (2021-2032)
  12. 6.6.2 North America Sanger Sequencers Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sanger Sequencers Sales Value (2021-2032)
  15. 6.7.2 Europe Sanger Sequencers Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sanger Sequencers Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sanger Sequencers Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sanger Sequencers Sales Value (2021-2032)
  21. 6.9.2 South America Sanger Sequencers Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sanger Sequencers Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sanger Sequencers Sales Value Share by Country, 2025 VS 2032
7 Sanger Sequencers Country-level Sales and Value Analysis
  1. 7.1 Global Sanger Sequencers Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sanger Sequencers Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sanger Sequencers Sales by Country (2021-2032)
  4. 7.3.1 Global Sanger Sequencers Sales by Country (2021-2026)
  5. 7.3.2 Global Sanger Sequencers Sales by Country (2027-2032)
  6. 7.4 Global Sanger Sequencers Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sanger Sequencers Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sanger Sequencers Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sanger Sequencers Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sanger Sequencers Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sanger Sequencers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sanger Sequencers Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sanger Sequencers Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sanger Sequencers Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sanger Sequencers Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sanger Sequencers Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sanger Sequencers Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sanger Sequencers Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sanger Sequencers Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sanger Sequencers Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sanger Sequencers Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sanger Sequencers Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sanger Sequencers Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sanger Sequencers Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sanger Sequencers Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sanger Sequencers Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sanger Sequencers Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sanger Sequencers Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sanger Sequencers Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sanger Sequencers Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sanger Sequencers Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sanger Sequencers Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sanger Sequencers Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sanger Sequencers Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sanger Sequencers Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sanger Sequencers Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sanger Sequencers Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sanger Sequencers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Danaher
  2. 8.1.1 Danaher Company Information
  3. 8.1.2 Danaher Business Overview
  4. 8.1.3 Danaher Sanger Sequencers Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Danaher Sanger Sequencers Product Portfolio
  6. 8.1.5 Danaher Recent Developments
  7. 8.2 Promega
  8. 8.2.1 Promega Company Information
  9. 8.2.2 Promega Business Overview
  10. 8.2.3 Promega Sanger Sequencers Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Promega Sanger Sequencers Product Portfolio
  12. 8.2.5 Promega Recent Developments
  13. 8.3 Denogen (Beijing) Bio-Sci&Tech
  14. 8.3.1 Denogen (Beijing) Bio-Sci&Tech Company Information
  15. 8.3.2 Denogen (Beijing) Bio-Sci&Tech Business Overview
  16. 8.3.3 Denogen (Beijing) Bio-Sci&Tech Sanger Sequencers Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Denogen (Beijing) Bio-Sci&Tech Sanger Sequencers Product Portfolio
  18. 8.3.5 Denogen (Beijing) Bio-Sci&Tech Recent Developments
  19. 8.4 Ningbo HEALTH Gene Technologies
  20. 8.4.1 Ningbo HEALTH Gene Technologies Company Information
  21. 8.4.2 Ningbo HEALTH Gene Technologies Business Overview
  22. 8.4.3 Ningbo HEALTH Gene Technologies Sanger Sequencers Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ningbo HEALTH Gene Technologies Sanger Sequencers Product Portfolio
  24. 8.4.5 Ningbo HEALTH Gene Technologies Recent Developments
  25. 8.5 Thermo Fisher Scientific
  26. 8.5.1 Thermo Fisher Scientific Company Information
  27. 8.5.2 Thermo Fisher Scientific Business Overview
  28. 8.5.3 Thermo Fisher Scientific Sanger Sequencers Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific Sanger Sequencers Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Recent Developments
  31. 8.6 Superyears Gene
  32. 8.6.1 Superyears Gene Company Information
  33. 8.6.2 Superyears Gene Business Overview
  34. 8.6.3 Superyears Gene Sanger Sequencers Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Superyears Gene Sanger Sequencers Product Portfolio
  36. 8.6.5 Superyears Gene Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sanger Sequencers Value Chain Analysis
  2. 9.1.1 Sanger Sequencers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sanger Sequencers Sales Mode & Process
  6. 9.2 Sanger Sequencers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sanger Sequencers Distributors
  9. 9.2.3 Sanger Sequencers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst